TreatmentMagnetic resonance imagingLaboratory testsThe diagnosis of multiple sclerosis (MS) still rests on the time-honored twin criteria of dissemination in time and space. The disease shows a predilection for certain parts of the central nervous system: the optic nerves and chiasm, the brain stem...
Treating multiple sclerosis costs a great deal for patients and communities. Individually, the nearly 1 million people with MS pay an average annual cost of more than $88,000 for the various treatment options, devices, daily living needs, and insurance needed for their condition. Overall, indirec...
Multiple sclerosis commonly affects the cerebellum, the portion of the brain responsible for balance and fine motor coordination. Consequently, people with multiple sclerosis often have difficulty maintaining their balance when walking and performing delicate tasks with their hands. The unexplained dropping ...
Symptomatic therapies and rehabilitation, however, remain the mainstay of treatment for the majority of patients with MS. The immunopathogenesis of MS and its treatments, both disease modifying and symptomatic, are reviewed below. 展开 关键词: multiple sclerosis patient adherence quality of life ...
Multiple sclerosis medications are prescribed to treat multiple sclerosis (MS), an autoimmune disorder that affects the central nervous system (CNS). These medications may prevent or slow down progression of MS and related disabilities, reduce duration a
Multiple sclerosis (MS) has a worldwide distribution but is five times more common in temperate regions than in tropical regions. Thediseaseprimarily occurs in individuals between ages 20 and 40, and women are affected by the disease more often than men. ...
1. Relapsing-remitting multiple sclerosis (RRMS) Relapsing-remitting multiple sclerosis (RRMS) is the most common form of MS. People with this form of disease develop symptoms that respond to treatment and then resolve. The development of symptoms is often referred to as an exacerbation of the ...
Plasmapheresis (plasma exchange):This therapy is sometimes attempted for treatment of severe attacks of the disease that do not respond to corticosteroids. This therapy is expensive, not FDA approved for multiple sclerosis, and its efficacy is controversial. ...
Dynamic network analysis of MEG data reveals spatiospectral activation profiles underpinning working memory impairment in multiple sclerosis, distinguishing between the disease-induced and treatment-related neurophysiological alterations. Chiara Rossi Diego Vidaurre ...
The objective of this study was to characterize the population of multiple sclerosis (MS) patients suffering from spasticity and to evaluate treatment patt... M Rizzo,O Hadjimichael,J Preiningerova,... - 《Multiple Sclerosis》 被引量: 447发表: 2004年 Treatments for spasticity and pain in mult...